GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vystar Corp (OTCPK:VYST) » Definitions » EV-to-EBIT

Vystar (Vystar) EV-to-EBIT : -0.33 (As of Apr. 25, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Vystar EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vystar's Enterprise Value is $0.58 Mil. Vystar's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.77 Mil. Therefore, Vystar's EV-to-EBIT for today is -0.33.

The historical rank and industry rank for Vystar's EV-to-EBIT or its related term are showing as below:

VYST' s EV-to-EBIT Range Over the Past 10 Years
Min: -31.19   Med: -4.94   Max: 1807.1
Current: -0.33

During the past 13 years, the highest EV-to-EBIT of Vystar was 1807.10. The lowest was -31.19. And the median was -4.94.

VYST's EV-to-EBIT is ranked worse than
100% of 1240 companies
in the Chemicals industry
Industry Median: 16.57 vs VYST: -0.33

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Vystar's Enterprise Value for the quarter that ended in Sep. 2023 was $0.92 Mil. Vystar's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.77 Mil. Vystar's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -192.42%.


Vystar EV-to-EBIT Historical Data

The historical data trend for Vystar's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vystar EV-to-EBIT Chart

Vystar Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.62 -4.49 -7.58 -4.71 -1.03

Vystar Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.85 -1.03 -0.88 -0.41 -0.52

Competitive Comparison of Vystar's EV-to-EBIT

For the Specialty Chemicals subindustry, Vystar's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vystar's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vystar's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vystar's EV-to-EBIT falls into.



Vystar EV-to-EBIT Calculation

Vystar's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.582/-1.774
=-0.33

Vystar's current Enterprise Value is $0.58 Mil.
Vystar's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vystar  (OTCPK:VYST) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Vystar's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-1.774/0.9219426
=-192.42 %

Vystar's Enterprise Value for the quarter that ended in Sep. 2023 was $0.92 Mil.
Vystar's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vystar EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Vystar's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Vystar (Vystar) Business Description

Traded in Other Exchanges
N/A
Address
725 Southbridge Street, Worcester, MA, USA, 01610
Vystar Corp is engaged in the rubber and plastic products market. It develops technology to produce Vytex Natural Rubber Latex which reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The company's products and services include Natural Rubber Latex, and clinical sleep diagnostics and durable medical equipment. The company derives revenue from sales of or license fees of Vytex NRL raw material to manufacturers and distributors of rubber and rubber end products.
Executives
Byron Lee Novosad other: Board Member 14019 SW FREEWAY, # 301 PMB 181, SUGAR LAND TX 77478
Bryan Lawrence Stone director C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Keith D. Osborn 10 percent owner 5671 PEACHTREE-DUNWOODY RD., ATLANTA GA 30342
Paul R. Oristaglio director 955 COUNTY ROAD, BARRINGTON RI 02806
Steven Rotman director, officer: Chief Executive Officer C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Joseph Carmen Allegra director C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
William R. Doyle director, officer: Chairman, President & CEO VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Joseph Allegra director VYSTAR CORPORATION, 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Jason M. Meggs director C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Ranjit K. Matthan director C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Mangum Michelle (mitsy) Y. director VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Michael X Ianacone director C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Thomas L Mills director C/O WINSTON & STRAWN,, 1400 L. STREET, N.W, WASHINGTON DC 20005
Paul A. Yeoham director C/O VYSTAR CORP., 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Dale Thomas Marsh director C/O VYSTAR CORPORATION, 3235 SATELLITE BLVD., BLDG. 400, STE 290, DULUTH GA 30096